The cold sore-causing Herpes Simplex Virus (HSV-1) hijacks human cells and reconfigures its DNA within just an hour after ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...

Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines.

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...

Seit hundert Tagen sitzt Ekrem İmamoğlu schon in Haft. In Istanbul sind erneut Zehntausende für die Freilassung des ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Etwa 300.000 Deutsche erkranken jährlich an Gürtelrose. Besonders im Gesicht ist die Entzündung "risikobehaftet", so ...

The GIP's own recommendations, published in February, also called for H1N1, H3N2, and B/Victoria lineage strains for vaccines intended for the 2025-26 season.

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.